Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
NRSN | US
0.03
2.80%
Healthcare
Biotechnology
30/06/2024
21/10/2024
1.10
1.08
1.10
1.04
NeuroSense Therapeutics Ltd. a clinical-stage biotechnology company focuses on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases in the United States and internationally. Its lead product is PrimeC an extended-release oral formulation of a fixed dose combination of ciprofloxacin and celecoxib for the treatment of amyotrophic lateral sclerosis. The company's preclinical pipeline includes StabiliC for the treatment of Parkinson's disease; and CogniC for the treatment of Alzheimer's disease. NeuroSense Therapeutics Ltd. was incorporated in 2017 and is headquartered in Herzliya Israel.
View LessLow Debt to Equity (< 0.25)
Price Below SMA10D
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
98.2%1 month
79.9%3 months
89.7%6 months
91.7%-
-
4.15
-0.02
0.02
-1.16
-
-
-11.69M
21.79M
21.79M
-
-
-
-
-494.84
1.04
1.83
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.37
Range1M
0.47
Range3M
0.86
Rel. volume
0.37
Price X volume
61.36K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
RenovoRx Inc. Common Stock | RNXT | Biotechnology | 0.9949 | 23.86M | -0.51% | n/a | 0.00% |
Unity Biotechnology Inc | UBX | Biotechnology | 1.4 | 23.59M | 0.00% | n/a | 109.64% |
HCW Biologics Inc. Common Stock | HCWB | Biotechnology | 0.5361 | 23.39M | 3.08% | n/a | -159.13% |
Aligos Therapeutics Inc | ALGS | Biotechnology | 7.29 | 23.30M | 0.55% | n/a | 14.63% |
Cyclo Therapeutics Inc | CYTH | Biotechnology | 0.81 | 23.24M | 4.65% | n/a | -58.50% |
Spruce Biosciences Inc | SPRB | Biotechnology | 0.5467 | 22.58M | 5.34% | n/a | 6.24% |
PolyPid Ltd | PYPD | Biotechnology | 3.3 | 22.45M | -8.08% | n/a | 689.01% |
BioXcel Therapeutics Inc | BTAI | Biotechnology | 0.5492 | 22.38M | -2.93% | n/a | -139.46% |
Pieris Pharmaceuticals Inc | PIRS | Biotechnology | 16.8 | 22.18M | -0.70% | n/a | 0.00% |
Inhibikase Therapeutics Inc. | IKT | Biotechnology | 2.22 | 22.15M | 4.23% | n/a | 3.49% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Beasley Broadcast Group Inc | BBGI | Broadcasting - Radio | 13.44 | 20.47M | 4.19% | n/a | 204.46% |
ILAG | ILAG | Building Products & Equipment | 1 | 18.06M | -2.91% | n/a | 5.48% |
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.5263 | 7.69M | -2.17% | 0.03 | 16.03% |
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.4659 | 4.44M | -2.96% | n/a | 19.98% |
Forza X1 Inc | FRZA | Recreational Vehicles | 0.19 | 2.99M | -13.68% | n/a | 0.97% |
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.06 | 2.71M | 0.00% | n/a | 17.32% |
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 3.65 | 2.01M | -6.89% | n/a | 0.00% |
Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.011 | 1.01M | 10.00% | n/a | -37.05% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -1.16 | 0.53 | Cheaper |
Ent. to Revenue | - | 3,967.00 | - |
PE Ratio | - | 41.03 | - |
Price to Book | 4.15 | 15.55 | Cheaper |
Dividend Yield | - | 2.20 | - |
Std. Deviation (3M) | 89.75 | 72.80 | Riskier |
Debt to Equity | -0.02 | -1.23 | Expensive |
Debt to Assets | 0.02 | 0.25 | Cheaper |
Market Cap | 21.79M | 3.66B | Emerging |